ASCO 2026 Genitourinary Cancers Symposium

At the ASCO Genitourinary Cancers Symposium held on February 26–28, 2026, combinations of precision medicines, targeted agents such as belzutifan and AI-supported biomarker strategies came to the forefront in prostate, kidney, bladder and testicular cancers. This category brings together the latest clinical trial results presented at the meeting and expert commentary.